Absci (ABSI) Operating Expenses (2020 - 2026)
Absci (ABSI) posted Operating Expenses of $31.1 million for Q1 2026, down 1.99% sequentially from $31.7 million in Q4 2025, and up 7.45% YoY from $28.9 million in Q1 2025.
Absci (ABSI) Operating Expenses (2020 - 2026) Analysis & Trends
Absci has reported Operating Expenses for 7 years, with the latest figure at $31.1 million in Q1 2026.
- Quarterly Operating Expenses rose 7.45% year-over-year to $31.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.3 million (up 6.22% YoY) and the FY2025 annual result came in at $123.1 million, up 8.55% from the prior year.
- Operating Expenses eased to $31.1 million in Q1 2026 per ABSI's latest filing, from $31.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $46.4 million in Q2 2023 and troughed at $22.6 million in Q4 2022.
- A 5-year average of $29.5 million and a median of $29.9 million in 2022 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses surged 142.58% in 2022, then sank 39.62% in 2024.
- Over 5 years, Operating Expenses stood at $22.6 million in 2022, then climbed by 10.72% to $25.1 million in 2023, then climbed by 21.38% to $30.4 million in 2024, then increased by 4.11% to $31.7 million in 2025, then fell by 1.99% to $31.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $31.1 million, $31.7 million, and $30.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 34.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.48 Mn |
| Mar 31, 2026 | 31.06 Mn |
| Dec 31, 2025 | 31.69 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 31.99 Mn |
| Mar 31, 2025 | 28.91 Mn |
| Dec 31, 2024 | 30.44 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Mar 31, 2024 | 24.40 Mn |
| Dec 31, 2023 | 25.08 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 46.36 Mn |
| Mar 31, 2023 | 25.75 Mn |
| Dec 31, 2022 | 22.65 Mn |
| Sep 30, 2022 | 30.34 Mn |
| Jun 30, 2022 | 29.89 Mn |
| Mar 31, 2022 | 29.62 Mn |
| Dec 31, 2021 | 27.71 Mn |
| Sep 30, 2021 | 22.68 Mn |